Optimising regorafenib dosing in mCRC
Optimising regorafenib dosing in mCRC
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer
An overview of the latest advances in gastric cancer
Supportive care in cancer treatment
Immunotherapy with radiation in metastatic pancreatic and colorectal adenocarcinoma
Using ctDNA to predict recurrence and response in colorectal cancer
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer
TRIBE2: Latest data for patients with mCRC
Entrectinib in NTRK-fusion positive gastrointestinal cancers
Implementing national cancer control plans